INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of net deferred tax assets

	December 31,
	2020		2021
Reserves and allowances	$	22	$	18
R&D expenses		482		399
Intangible assets		44		31
Stock-based compensation		134		33
Loss carryforward		1,551		3,322
Deferred tax assets before valuation allowance		2,233		3,803
Less – valuation allowance		(2,233)		(3,803)
Net deferred tax assets	$	—	$	—

Schedule of income tax provision

	Year ended December 31,
	2019		2020		2021
Current:
Israel	$	—	$	—	$	—
Foreign		146		158		7
Total current income tax expense		146		158		7
Deferred:
Domestic (Israel)		—		—		—
Foreign		—		—		—
Total deferred income tax expense		—		—		—
Income tax expense	$	146	$	158	$	7

CIK 0001822935 Healthcare Capital Corp

Schedule of net deferred tax assets

	December 31,		December 31,
	2021		2020
Deferred tax assets:
Net operating loss carryforward	$	38,737	$	289
Start-up and organizational costs		274,984		—
Total deferred tax assets		313,721		289
Valuation Allowance		(313,721)		(289)
Net deferred tax assets	$	—	$	—

Schedule of income tax provision

	December 31,		December 31,
	2021		2020
Federal
Current	$	—	$	—
Deferred		(313,432)		(289)
State and Local
Current		—		—
Deferred		—		—
Change in valuation allowance		313,432		289
Income tax provision	$	—	$	—

Schedule of reconciliation of the federal income tax rate

	December 31,		December 31,
	2021		2020
Statutory federal income tax rate	21.0	%	21.0	%
Change in fair value of warrants	(29.3)	%	0.0	%
Transaction costs allocated to warrant liabilities	2.0	%	0.0	%
Fair value of warrant liability in excess of purchase price paid for Private Placement Warrants	1.6	%	0.0	%
Facilitative Merger Costs	1.0	%
Valuation allowance	3.6	%	(21.0)	%
Income tax provision	0.0	%	0.0	%